Table 1.
Correlation between miR-424-5p expression and clinicopathological features in 83 EOCpatient.
| Relative miR-424-5p expression |
|||||
|---|---|---|---|---|---|
| Clinicopathological features | Number of patients | Low | High | χ2 | p value |
| ALL | 83 | 41 | 42 | ||
| Age | 0.9647 | 0.3260 | |||
| <55 | 38 | 21 | 17 | ||
| ≥55 | 45 | 20 | 25 | ||
| FIGO | 8.493 | 0.0036** | |||
| Early (I-II) | 57 | 22 | 35 | ||
| Advanced (III-IV) | 26 | 19 | 7 | ||
| Pathological grade | 4.525 | 0.0334* | |||
| Well/Moderately differentiated (G1-G2) | 52 | 21 | 31 | ||
| Poorly differentiated (G3) | 31 | 20 | 11 | ||
| Residual tumor siz (cm) | 5.655 | 0.0174* | |||
| <5 | 33 | 11 | 22 | ||
| ≥5 | 50 | 30 | 20 | ||
| Ascites (ml) | 1.491 | 0.2220 | |||
| <100 | 38 | 16 | 22 | ||
| ≥100 | 45 | 25 | 20 | ||
| Serum CA125 (U/ml) | 0.3552 | 0.596 | |||
| ≤35 | 31 | 14 | 17 | ||
| >35 | 52 | 27 | 25 | ||
| Lymph node metastasis | 4.226 | 0.0398* | |||
| Negative | 61 | 26 | 35 | ||
| Positive | 22 | 15 | 7 | ||
FIGO, international federation of gynecology and obstetrics according to the 2009 FIGO surgical staging system (*p < 0.05, ** p < 0.01).